Home/ Stocks/ IBO

Impact BioMedical, Inc.

IBO XASE

$0.53 -0.01 (-2.46%) ▼ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$54.15M

About Impact BioMedical, Inc.

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 8 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	N/A	$-2,284,000	$-0.02
FY 2025	N/A	$-11,870,000	$-0.38
Q3 2025	N/A	$-1,475,000	$-0.12
Q2 2025	N/A	$-14,352,000	$-1.18

TickerDaily Coverage

Why Is Impact BioMedical (IBO) Stock Up 95.4% Today?

Penny Stocks Marcus Rivera · Mar 5, 2026

Impact BioMedical (IBO) stock exploded 95.4% Wednesday, closing at $0.82 after opening at $0.4133....

View All Coverage →

Get IBO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Impact BioMedical, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.